ArticleNeurology(R) neuroimmunology & neuroinflammation2025
Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.